It has also been reported to be increased in MM and correlated significantly with serum β2-microglobulin levels and increases from stage I to III [41], and related with an inferior progression survival and overall survival in myeloma patients [42]. The gene discussed is HLA-G; the disease is plasma cell myeloma.